CMAAO Update 6th February on Corona 2019
nCoV
5% less cases on 5th 3723 cases as against
3927 on 4th similarly on 28th Jan cases dropped
Beware of Common Myths: There is no evidence that eating garlic cannot
prevent corona virus
Dr
KK Aggarwal
President
CMAAO, HCFI and Past National President IMA
Travel 4 advisory to china and Travel 2 to Kerala affected districts
DCGI approves combination of HIV drugs for corona infection
The
government in Delhi on Saturday set up a round-the-clock National Centre for
Disease Control Call Centre (+91-11-23978046) to attend to public
queries.
Kerala government declares coronavirus as state emergency. Three
primary cases in North, South and Central Kerala (Kasaragod district is
in north Kerala, Thrissur in central Kerala and Alappuzha in South Kerala].
Four Karnataka
districts bordering Kerala — Kodagu, Mangaluru, Chamarajanagar and Mysuru —
have been put on high alert in the wake of positive coronavirus cases in Kerala.
It is les likely to have the serious illness in
other countries. As patients with breathlessness are unlikely to board and patients
will mild illness or asymptomatic illness are less likely to transmit infections.
Beware of Myths
1. People receiving packages from China are not at risk of
contracting the new coronavirus. Coronaviruses do not survive long on objects,
such as letters or packages.
2. There is no evidence that companion animals/pets such as dogs or
cats can be infected with the new coronavirus. However, it is always a good
idea to wash your hands with soap and water after contact with pets. This
protects you against various common bacteria such as E. coli and Salmonella
that can pass between pets and humans.
3. Pneumococcal vaccine and Haemophilus influenza type B (Hib)
vaccine, do not provide protection against the new coronavirus.
4.
Regularly rinsing the nose with
saline does not protect people from infection with the new coronavirus. Rinsing
nose with saline can help people recover more quickly from the common cold.
However, regularly rinsing the nose has not been shown to prevent respiratory
infections.
5.
There is no evidence that using
mouthwash will protect you from infection with the new coronavirus. Some brands
or mouthwash can eliminate certain microbes for a few minutes in the saliva in
your mouth. However, this does not mean they protect you from 2019-nCoV
infection.
6.
Garlic is a healthy food that
may have some antimicrobial properties. However, there is no evidence from the
current outbreak that eating garlic has protected people from the new
coronavirus.
7.
Sesame oil does not kill the
new coronavirus. There are some chemical disinfectants that can kill the
2019-nCoV on surfaces. These include bleach/chlorine-based disinfectants,
either solvents, 75% ethanol, peracetic acid and chloroform. However, they have little or no
impact on the virus if you put them on the skin or under your nose. It can even
be dangerous to put these chemicals on your skin.
8.
People of all ages can be infected by
the new coronavirus (2019-nCoV). Older people, and people with pre-existing
medical conditions (such as asthma, diabetes, heart disease) appear to be more
vulnerable to becoming severely ill with the virus. WHO advises people of
all ages to take steps to protect themselves from the virus, for example by
following good hand hygiene and good respiratory hygiene?
9.
Antibiotics do not work against
viruses, only bacteria. The new coronavirus (2019-nCoV) is a virus and,
therefore, antibiotics should not be used as a means of prevention or
treatment. However, if you are hospitalized for the 2019-nCoV, you may receive
antibiotics because bacterial co-infection is possible.
10. To date, there is no specific medicine recommended to prevent or
treat the new coronavirus (2019-nCoV). However, those infected with the virus should receive appropriate care
to relieve and treat symptoms, and those with severe illness should receive
optimized supportive care. Some specific treatments are under investigation and
will be tested through clinical trials. WHO is helping to accelerate research
and development efforts with a range or partners?
Summary
Continue asking patients with suspected flu or
diarrhoea if they, or someone they have been in contact with, recently returned
from corona affected area. [ in US confirmed case they 2019-nCoV RNA in a stool specimen
collected on day 7 of the patient’s illness. ]
Corona is a Public Health Emergency of
International Concern (mandatory to
report to WHO human and animal cases) as person-to-person transmission in UK,
USA, Germany, Japan, Taiwan and Vietnam and two deaths, one in the Philippines
on Feb 2 (44 M) and 2nd in Hong Kong ( 39 M) on February outside
of mainland China.
The virus behaves like SARS with 2 % case
fatality (15% of admitted cases), time
to death 14 days, time to pneumonia 9
days, 3-4 reproductive number R0, has its origin from bats, spreads like large
droplets and predominately from people having lower respiratory infections and
hence universal droplet precautions the answer.
Status
The Novel Coronavirus (2019-nCoV) originating
from Wuhan, China, has now spread to 28 countries and
territories worldwide, with 28276 confirmed cases and 565
deaths.
NEJM: Among
the first 425 patients with confirmed NCIP, the median age was 59 years (2-74
yrs) and 56% were male. The majority of
cases (55%) with onset before January 1, 2020, were linked to the Huanan
Seafood Wholesale Market, as compared with 8.6% of the subsequent cases. The
mean incubation period was 5.2 days (95% confidence interval [CI], 4.1 to 7.0),
with the 95th percentile of the distribution at 12.5 days. In its early stages,
the epidemic doubled in size every 7.4 days. With a mean serial interval of 7.5
days (95% CI, 5.3 to 19), the basic reproductive number was estimated to be 2.2
(95% CI, 1.4 to 3.9).
71%, deaths more in comorbid cases, Just like SARS, it mostly
do not affect children 15 years or less of age). 73 deaths on 5th
( 15% rise), 66 on 4th, 64 on
3rd Feb. Anticipates one lac already infected.
Countries and territories that have confirmed cases: Thailand,
Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia,
France, the United States, South Korea, Germany, the United Arab Emirates,
Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri
Lanka, Finland, Sweden and Spain.
Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan,
France and the United States involved patients who had not to China.
It’s
not new
Every
decade a zoonotic coronavirus crosses species to infect human populations and
in this decade, we have a virus, provisionally called 2019-nCoV, first
identified in Wuhan, China, in persons exposed to a seafood or wet market in
Mid December 2019
CORONA:
Crown or Coronary artery
Virus has an RNA core and belongs to the
corona virus family. ‘corona’ means crown or the halo surrounding the sun. The
arteries supplying oxygen to the heart are also called coronary arteries,
because the heart is considered the crown. In electron microscope, it is round
with spikes poking out from its periphery.
The
three deadly human respiratory coronaviruses viruses so far
Severe
acute respiratory syndrome coronavirus [SARS-CoV]
Middle
East respiratory syndrome coronavirus [MERS-CoV])
2019-nCoV:
The virus is 75 to 80% identical to the SARS-CoV
The
virus
2019-nCoV is sufficiently divergent from
SARS-CoV to be considered a new human-infecting beta coronavirus. Structural
analysis suggests that 2019-nCoV might be able to bind to the
angiotensin-converting enzyme 2 receptor in humans. It is a single-strand,
positive-sense RNA genome ranging from 26 to 32 kilobases in length.
The
case fatality is lower than SARS, MERS and EBOLA
2019
nCoV mortality rate is 2% ( earlier thought to be 3%) compared to MERS 34%, SARS
(out of 5327 cases) 10%, Ebola 50%, Small Pox 30-40%, Measles 10-15% developing
countries, Polio 2-5% children and 15-30% adults, Diphtheria 5-10%, Whooping
cough 4% infants < 1yr, 1% children < 4 years AND Swine flu < 0.1-4 %.
Once the province Hubei (where the epicentre Wuhan is situated)
is removed from the calculation, the national (China) mortality rate drops to
0.3%. Within the Hubei province, the mortality rate is about 1% when excluding
the city of Wuhan (where it is 5.5%).
Role of CMAAO and other Medical Associations
All countries should be prepared for
containment, including active surveillance, early detection,
isolation and case management, contact tracing and prevention of onward
spread of the virus and to share full data with WHO. All countries
are legally required to share information with WHO under
the IHR.
Any detection of 2019-nCoV in an animal (including
information about the species, diagnostic tests, and relevant epidemiological
information) should be reported to the World Organization for Animal
Health (OIE) as an emerging disease.
All countries should emphasise on reducing human
infection, prevention of secondary transmission and international spread.
Its
Zoonotic but It is unlikely to spread through seafood in
India
It
is closely related to several bat coronaviruses. Bats are the primary reservoir
for the virus. SARS-CoV was transmitted to humans from exotic animals in wet
markets, whereas MERS-CoV is transmitted from camels to humans. In both
cases, the ancestral hosts were probably bats.
The virus has been traced to snakes in China, so, it is unlikely
to spread in India through sea food. Snakes often hunt for bats in wild. Reports
indicate that snakes were sold in the local seafood market in Wuhan, raising
the possibility that the 2019-nCoV might have jumped from the host species -
bats - to snakes and then to humans at the beginning of the outbreak. However,
it remains a mystery as to how the virus could adapt to both the cold-blooded
and warm-blooded hosts.
It
is more infectious to humans
Notably,
2019-nCoV grows better in primary human airway epithelial cells than in
standard tissue-culture cells, unlike SARS-CoV or MERS-CoV. It is likely that 2019-nCoV
will behave more like SARS-CoV.
Human
to Human infection
Both
SARS-CoV and MERS-CoV infect intrapulmonary epithelial cells more than cells of
the upper airways. Consequently, transmission occurs primarily from
patients with recognized illness and not from patients with mild, nonspecific
signs. Though NEJM has reported a case of 2019-nCoV infection acquired outside of Asia in which
transmission appears to have occurred during the incubation period in the index
patient but the same has been challenged now.
It
appears that 2019-nCoV uses the same cellular receptor as SARS-CoV (human
angiotensin-converting enzyme 2 [hACE2]), so transmission is
expected only after signs of lower respiratory tract disease develop.
The paramount reason for
breathless is the fact that this new virus attacks the lungs and not just the
throat. Patients so far have not presented with a sore throat, the reason being
that the 2019-nCoV launches an attack at the intraepithelial cells of lung
tissue.
One report of a small cluster of five cases
suggested transmission from asymptomatic individuals during the incubation
period; all patients in this cluster had mild illness. Another case got infected
while using gown, but eyes not covered.
It’s predominantly a large droplet
infection
Transmission
of 2019-nCoV probably occurs by means of large droplets and
contact and less so by means of aerosols and fomites, based on experience with
SARS-CoV and MERS-CoV. In lab we need minimum BSL 2 or 3 (not BSL 4 facilities)
to prevent transmission.
The incubation periods
Up to 2 weeks, according to WHO. Mean 5.5 days
Symptoms
One-third landed up in the
intensive care unit; and as many as 15% of these succumbed to the infection.
Almost all patients presented with fever, more than two-thirds had cough and
almost 50% suffered from weakness or muscle ache. More than half complained of
shortness of breath.
2019-nCoV not unlike other
virus disease presents with low white cells and reduction in lymphocyte count
and raised liver transaminase levels.
Most infected patients experience milder symptoms,
but about 1 in 5 people have severe illness, including pneumonia and
respiratory failure.
|
Clinical features
|
|
Epidemiologic risk
|
|
Fever* or signs/symptoms of lower respiratory illness
(cough or shortness of breath)
|
PLUS
|
Any person, including health care workers,
who has had close contact¶ with a
laboratory-confirmed◊ 2019-nCoV
patient within 14 days of
symptom onset
|
|
Fever* and signs/symptoms of
lower respiratory illness (cough or shortness of breath)
|
PLUS
|
A history of travel from Hubei Province,
China within 14 days of symptom onset
|
|
Fever* and signs/symptoms of
lower respiratory illness (cough or shortness of breath) requiring
hospitalization◊
|
PLUS
|
A history of travel from mainland China
within 14 days of symptom onset
|
nCoV: novel coronavirus; CDC: United States Centers
for Disease Control and Prevention; NIOSH: National Institute for Occupational
Safety and Health.
* Fever may be subjective or confirmed.
¶ CDC definition of close contact (any of following):
Being within approximately 6 feet (2 meters) or within the room or care
area of a 2019-nCoV case for a prolonged period of time while not wearing
recommended personal protective equipment (gowns, gloves, NIOSH-certified
disposable N95 respirator, eye protection); close contact can include caring
for, living with, visiting, or sharing a health care waiting area or room with
a 2019-nCoV case.
Having direct contact with infectious secretions of a 2019-nCoV case (e.g.,
being coughed on) while not wearing recommended personal protective equipment.
Δ Documentation of laboratory confirmation of
2019-nCoV may not be possible for travellers or persons caring for patients in
other countries.
◊ This category also includes any member of a
cluster of patients with severe acute lower respiratory illness (e.g.,
pneumonia, acute respiratory distress syndrome) of unknown aetiology in whom
2019-nCoV is being considered that requires hospitalization. Such persons should
be evaluated in consultation with state and local health departments regardless
of travel history.
Drugs
There is no proven antiviral treatment. A
combination of lopinavir and ritonavir did show some promise in patients with
SARS, but this was in the lab and not in humans. A randomised study is being
done in Saudi Arabia in patients with MERS; a combination of lopinavir,
ritonavir and recombinant interferon beta-1b versus placebo; the results are
awaited.
Scientists in Australia have
reportedly recreated a lab-grown version of coronavirus. The breakthrough would help researchers around the world as they
race to develop a vaccine and detection tests.
Chloroquine, which has potent antiviral activity against the SARS-CoV, has been shown to have similar activity against HCoV-229E in cultured cells and against HCoV-OC43 both in cultured cells and in a mouse model. However, there have been no studies of efficacy in humans.
Thai doctors have used oseltamivir along with lopinavir and
ritonavir, both HIV drugs. An experimental drug from Gilead Sciences Inc.,
called remdesevir, has encouraging results.
Arbidol,
an antiviral drug used in Russia and China for treating influenza, could be
combined with Darunavir, the anti-H.I.V. drug, for treating patients with the
coronavirus. {the corona virus shares some similarity to HIV virus also)
PVP-I mouthwashes and gargles significantly reduce
viral load in the oral cavity and the oropharynx. The importance of PVP-I has
been emphasised by its inclusion in the World Health Organization’s list of
essential medicines, and high potency for viricidal activity has been observed
against viruses of significant global concern, including hepatitis A and
influenza, as well as the Middle-East Respiratory Syndrome and Sudden Acute
Respiratory Syndrome coronaviruses.
The
Drug Controller General of India (DGCI) today approved the "restricted
use" of a combination of drugs used widely for controlling HIV infection
in public health emergency for treating those affected by novel coronavirus
(nCoV).
Universal
droplets precaution the answer
Quarantining
for two weeks
Timely
diagnosis
Strict
adherence to universal precautions
Wash your hands often with soap and water for at least 20 seconds. If
soap and water are not available, use an alcohol-based hand sanitizer.
Avoid touching your eyes, nose, and mouth with unwashed hands.
Avoid close contact with people who are sick.
Stay home when you are sick.
Cover your cough or sneeze with a tissue, then throw the tissue in the
trash.
Clean and disinfect frequently touched objects and surfaces.
These are everyday habits that can help prevent the spread of several
viruses!
Travel
Requires
contact of ten minutes within six feet
The
virus can remain alive on any surface for 3-12 hours
Choosing a window seat and staying put clearly lowers your likelihood of
encountering an infectious disease.
Level 1 - Exercise normal safety precautions
Level 2 - Exercise a high degree of caution (Affected areas in Kerala)
Level 3 - Reconsider your need to travel (advisory for corona affected
countries)
Level 4 - Do not travel (advisory for china)
Hong Kong has imposed 14 days quarantine on
people arriving from china.
The Karnataka
government has ordered that anybody arriving from the 23 coronavirus
affected countries must stay in isolation at home for 28 days. The home
isolation requirement is irrespective of the virus symptoms.
Contagiousness
The reproduction number—R0 or “r naught”—simply refers to the
number of additional people that an infected person typically makes sick.
A more recent study is indicating a Ro as high as 4.08. This
value substantially exceeds WHO's estimate (made on Jan. 23) of between 1.4 and
2.5] and is also higher than recent estimates between 3.6 and 4.0
and between 2.24 to 3.58. Preliminary studies had estimated Ro to be between 1.5
and 3.5. Based on
these numbers, on average every case of the Novel Coronavirus would create 3 to
4 new cases. An outbreak with a reproductive number of below 1 will gradually
disappear. The Ro for the common flu is 1.3 and for SARS it was 2.0.
Detection
of 2019-nCoV RNA in specimens from the upper respiratory tract with low Ct
values on day 4 and day 7 of illness is suggestive of high viral loads and
potential for transmissibility. [NEJM]
Risk
Assessment
The risk depends
on characteristics of the virus, including whether and how well it spreads
between people, the severity of resulting illness, and the medical or other
measures available to control the impact of the virus (for example, vaccine or
treatment medications).
The risk to individuals is dependent on exposure. At this time, some people will have an increased risk of infection, for example healthcare workers caring for 2019-nCoV patients and other close contacts of 2019-nCoV patients. For the general public, who are unlikely to be exposed to this virus, the immediate health risk from 2019-nCoV is considered low at this time.
The risk to individuals is dependent on exposure. At this time, some people will have an increased risk of infection, for example healthcare workers caring for 2019-nCoV patients and other close contacts of 2019-nCoV patients. For the general public, who are unlikely to be exposed to this virus, the immediate health risk from 2019-nCoV is considered low at this time.
Evacuation
Tokyo, Japan, India have evacuated their citizens trapped in
China affected areas
Coronavirus: Mass Quarantine May Spark
Irrational Fear, Anxiety, Stigma
Comparisons:
Every year an estimated 290,000 to 650,000 people die in the world due
to complications from seasonal influenza (flu) viruses. This figure
corresponds to 795 to 1,781 deaths per day due to the seasonal flu.
SARS (Nov. 2002 - Jul. 2003): was a coronavirus that originated from
Beijing, China, spread to 29 countries, with 8,096 people infected and 774
deaths (with a fatality rate of 9.6%). Considering that SARS ended up infecting
5,237 people in mainland China, Wuhan Coronavirus surpassed SARS on January 29,
2020, when Chinese officials confirmed 5,974 cases of the novel coronavirus
(2019-nCoV). One day later, on January 30, 2020 the novel coronavirus cases
surpassed even the 8,096 cases worldwide representing the final SARS count in
2003.
MERS (2012) killed 858 people out of the 2,494 infected (with a fatality
rate of 34.4%).
PMO
Suggestions
7th
January: CMAAO Alert: WHO to
monitor China's mysterious pneumonia of unknown virus outbreak
8th
Jan: CMAAO warns Asian citizens
travelling China over mystery pneumonia outbreak
10th
January: I wrote an editorial: Corona virus
strain causing pneumonia in Wuhan, China, It’s a new strain of corona virus in the
china pneumonia
13th January:
China Virus Outbreak Linked to Seafood Market:
China Virus Outbreak Linked to Seafood Market:
15th January:
First Case China Pneumonia Virus Found Outside China in Thailand
First Case China Pneumonia Virus Found Outside China in Thailand
17th January: WHO issues warning
after 'mysterious' Chinese corona virus spreads to Japan
17th Jan: India at threat of Corona. CMAAO urges travel advisory on
coronavirus: http://www.drugtodayonline.com/medical-news/nation/10379-cmaao-urges-travel-advisory-on-coronavirus.html
(18th Indian govt issues travel
advisory as China's mysterious 'Coronavirus' spread in other countries)
18th Jan:
WHO issues warning after mysterious Chinese Coronavirus spreads to
Japan [http://blogs.kkaggarwal.com/tag/who/]
18-20
Jan: Three countries meet, also discussed Corona virus
22nd
Jan: Still not being declared to be a notifiable disease, N 95 to be included
in the list of essential drugs and prise capped, Oseltamivir, should
also be prise capped, air flights should have available air masks for all
passengers, not declaring flu like symptoms while boarding or landing should be
a punishable offence (23rd India advisory to airports)
24th:
Inter Ministerial Committee needs to be formed on Corona Virus (PMO took a
meeting on 24th evening)
25th
Jan: Indian government should pay for Indians affected with the virus in China
26
Jan: Need of National droplet Infection Control program, Policy to ban export
of face masks, policy to evacuate Indians from China affected areas,
Time to collaborate on Nosode therapy (Exports of masks banned on 31st
January by Indian Government)
27:
History of anti-fever drugs at airports should be taken
28:
Do research on Nosodes
29:
Closure of live markets all over the world, India should take a lead
30:
Paid flu leave, surgical mask at public places, N 95 for health care providers
31:
Respiratory hygiene advisory schools, Pan India task force to be made
1st
Feb: Disaster Budget is the need of the hour
3rd
Feb: 100 crore budget for Corona virus; Private labs to be recognised; one
dedicated corona National help line, MTNL BSNL to have a line of advisory in
their bills, isolation wards to be single rooms or two beds separated with six
feet distance, national insurance to cover cost of treatment, suspend AI flights to China and Hong Kong [New Delhi, Feb 4 (IANS) National passenger carrier Air India on
Tuesday said that it will suspend flight services to Hong Kong owing to the
outbreak of deadly coronavirus. The suspension will come into force from Friday until March 28, the
airline said in a statement. Earlier, Air India had cancelled its flight to Shanghai from January 31
to February 14.] Sea ports ton have same precautions, prize caps for masks and
gloves, National droplet control program, clarification that import of goods is
not risky]
4th
Feb: Kerala travel advisory needed [The Union Ministry of Health and Family
Welfare issued a fresh travel advisory on Monday urging people to refrain from
visiting China]
Confirmed Cases and Deaths by Country and Territory
(Affecting 28 countries
and territories)
Search:
|
Country
|
Cases
|
Deaths
|
Region
|
|
China
|
28,018
|
563
|
Asia
|
|
Japan
|
45
|
0
|
Asia
|
|
Singapore
|
28
|
0
|
Asia
|
|
Thailand
|
25
|
0
|
Asia
|
|
South Korea
|
23
|
0
|
Asia
|
|
Hong Kong
|
21
|
1
|
Asia
|
|
Australia
|
14
|
0
|
Australia/Oceania
|
|
Malaysia
|
12
|
0
|
Asia
|
|
United States
|
12
|
0
|
North America
|
|
Germany
|
12
|
0
|
Europe
|
|
Taiwan
|
11
|
0
|
Asia
|
|
Macao
|
10
|
0
|
Asia
|
|
Vietnam
|
10
|
0
|
Asia
|
|
France
|
6
|
0
|
Europe
|
|
Canada
|
5
|
0
|
North America
|
|
United Arab Emirates
|
5
|
0
|
Asia
|
|
Philippines
|
3
|
1
|
Asia
|
|
India
|
3
|
0
|
Asia
|
|
Russia
|
2
|
0
|
Europe
|
|
Italy
|
2
|
0
|
Europe
|
|
United Kingdom
|
2
|
0
|
Europe
|
|
Finland
|
1
|
0
|
Europe
|
|
Sweden
|
1
|
0
|
Europe
|
|
Sri Lanka
|
1
|
0
|
Asia
|
|
Cambodia
|
1
|
0
|
Asia
|
|
Nepal
|
1
|
0
|
Asia
|
|
Spain
|
1
|
0
|
Europe
|
|
Belgium
|
1
|
0
|
Europe
|
Total Deaths of Novel Coronavirus
(2019-nCoV)
|
Date
|
Total
Deaths |
Change
in Total |
Change in
Total (%) |
|
Feb. 5
|
565
|
73
|
15%
|
|
Feb. 4
|
492
|
66
|
15%
|
|
Feb. 3
|
426
|
64
|
18%
|
|
Feb. 2
|
362
|
58
|
19%
|
|
Feb. 1
|
304
|
45
|
17%
|
|
Jan. 31
|
259
|
46
|
22%
|
|
Jan. 30
|
213
|
43
|
25%
|
|
Jan. 29
|
170
|
38
|
29%
|
|
Jan. 28
|
132
|
26
|
25%
|
|
Jan. 27
|
106
|
26
|
33%
|
|
Jan. 26
|
80
|
24
|
43%
|
|
Jan. 25
|
56
|
15
|
37%
|
|
Jan. 24
|
41
|
16
|
64%
|
|
Jan. 23
|
25
|
8
|
47%
|
Daily Deaths of Novel Coronavirus
(2019-nCoV)
|
Date
|
Daily
Deaths |
Change
in Daily |
Change in
Daily (%) |
|
Feb. 5
|
73
|
7
|
11%
|
|
Feb. 4
|
66
|
2
|
3%
|
|
Feb. 3
|
64
|
6
|
10%
|
|
Feb. 2
|
58
|
13
|
29%
|
|
Feb. 1
|
45
|
-1
|
-2%
|
|
Jan. 31
|
46
|
3
|
7%
|
|
Jan. 30
|
43
|
5
|
13%
|
|
Jan. 29
|
38
|
12
|
46%
|
|
Jan. 28
|
26
|
0
|
0%
|
|
Jan. 27
|
26
|
2
|
8%
|
|
Jan. 26
|
24
|
9
|
60%
|
|
Jan. 25
|
15
|
-1
|
-6%
|
|
Jan. 24
|
16
|
8
|
100%
|
|
Jan. 23
|
8
|
0
|
0%
|
Total Cases of Novel Coronavirus
(2019-nCoV)
|
Date
|
Total
Cases |
Change
in Total |
Change in
Total (%) |
|
Feb. 5
|
28,276
|
3,723
|
15%
|
|
Feb. 4
|
24,553
|
3,927
|
19%
|
|
Feb. 3
|
20,626
|
3,239
|
19%
|
|
Feb. 2
|
17,387
|
2,836
|
19%
|
|
Feb. 1
|
14,551
|
2,603
|
22%
|
|
Jan. 31
|
11,948
|
2,127
|
22%
|
|
Jan. 30
|
9,821
|
2,005
|
26%
|
|
Jan. 29
|
7,816
|
1,755
|
29%
|
|
Jan. 28
|
6,061
|
1,482
|
32%
|
|
Jan. 27
|
4,579
|
1,778
|
63%
|
|
Jan. 26
|
2,801
|
786
|
39%
|
|
Jan. 25
|
2,015
|
703
|
54%
|
|
Jan. 24
|
1,312
|
468
|
55%
|
|
Jan. 23
|
844
|
265
|
46%
|
Daily Cases of Novel Coronavirus (2019-nCoV)
|
Date
|
Daily
Cases |
Change
in Daily |
Change in
Daily (%) |
|
Feb. 5
|
3,723
|
-204
|
-5%
|
|
Feb. 4
|
3,927
|
688
|
21%
|
|
Feb. 3
|
3,239
|
403
|
14%
|
|
Feb. 2
|
2,836
|
233
|
9%
|
|
Feb. 1
|
2,603
|
476
|
22%
|
|
Jan. 31
|
2,127
|
122
|
6%
|
|
Jan. 30
|
2,005
|
250
|
14%
|
|
Jan. 29
|
1,755
|
273
|
18%
|
|
Jan. 28
|
1,482
|
-296
|
-17%
|
|
Jan. 27
|
1,778
|
992
|
126%
|
|
Jan. 26
|
786
|
83
|
12%
|
|
Jan. 25
|
703
|
235
|
50%
|
|
Jan. 24
|
468
|
203
|
77%
|
|
Jan. 23
|
265
|
132
|
99%
|
We
No comments:
Post a Comment